跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Seroflo 125 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Seroflo 125
Approved
STANDARD
Seroflo 125
Cipla Ltd. (Unit II)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7d288a8e7cad9ca7
Company
Cipla Ltd. (Unit II)
Type
Standard
Approval Details
Approval Id
7d288a8e7cad9ca7
Drug Approval Philippines Name
Seroflo 125
Product Name
Seroflo 125
Registration Number
DRP-10194
Brand Name
Seroflo 125
Generic Name
Salmeterol (As Xinafoate) + Fluticasone Propionate
Dosage Form
Metered Dose Inhaler (CFC Free) (120 doses)
Dosage Strength
25 mcg/125 mcg per Actuation
Manufacturer
Cipla Ltd. (Unit II)
Importer
Healol Pharma Corporation
Distributor
Healol Pharma Corporation
Issuance Date
26 October 2021
Expiry Date
31 January 2027
Pharmacologic Category
Anti-asthma
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7d288a8e7cad9ca7
Type
Standard
Back to Philippines FDA Approvals